In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $2.24 in the prior trading day, Larimar Therapeutics Inc (NASDAQ: LRMR) closed at $2.12, down -5.36%. In other words, the price has decreased by -$5.36 from its previous closing price. On the day, 0.78 million shares were traded.
Ratios:
Our goal is to gain a better understanding of LRMR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.48 and its Current Ratio is at 7.48. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on January 29, 2025, initiated with a Buy rating and assigned the stock a target price of $18.
On October 16, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $26.
On October 03, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $22.Wedbush initiated its Outperform rating on October 03, 2024, with a $22 target price.
Stock Price History:
Over the past 52 weeks, LRMR has reached a high of $11.20, while it has fallen to a 52-week low of $1.61. The 50-Day Moving Average of the stock is -10.18%, while the 200-Day Moving Average is calculated to be -59.25%.
Shares Statistics:
A total of 64.03M shares are outstanding, with a floating share count of 36.68M. Insiders hold about 42.71% of the company’s shares, while institutions hold 61.92% stake in the company.
